{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"25.260","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"198,913,232","primaryexch":"香港交易所","ric":"2480.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"K","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BN12HB5","am":"5.05","iv":"","ew_strike":"","as":"25.200","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"24.860","registrar":"卓佳證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"200","update_time":"2025-09-28 00:06:03.0","lo52":"20.000","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"","base_currency":null,"coupon":"","expiry_date":"","chairman":"孔健","underlying_ric":"2480.HK","hi52":"28.000","issuer_name":"北京綠竹生物技術股份有限公司 - B - H股","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日15:31","aum_date":"","lo":"25.260","mkt_cap":"5.01","f_aum_hkd":null,"ew_sub_per_to":"","ls":"25.200","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"+0.340","aum":"","issued_shares_class_B":null,"vo":"200","secondary_listing_flag":false,"listing_date":"2023年5月8日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"北京綠竹生物技術股份有限公司 - B - H股","nm_s":"綠竹生物－Ｂ","sym":"2480","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.020","strike_price":"","summary":"北京綠竹生物技術股份有限公司是一家主要從事疫苗及治療性生物製劑的研究、開發及生產的中國公司。該公司還從事開發創新型人用疫苗及治療性生物製劑，以預防及控制傳染病以及治療癌症及自身免疫性疾病。該公司的產品包括臨床階段的在研產品，以及臨床前階段的在研產品。核心產品LZ901，主要應用於預防年齡為50歲及以上成人水痘帶狀皰疹病毒引起的帶狀皰疹。該公司主要在國內市場開展其業務。","op":"25.260","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國北京市<br/>通州區<br/>工業開發區<br/>廣通街3號","pc":"+1.37","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"24.860","isin":"CNE100005YD8","moneyness":""}},"qid":"1759075376070"}
